Featured in The Nikkei
PRISM BioLab has been featured in The Nikkei (Nihon Keizai Shimbun). "PRISM BioLab and AI Drug...
Read More
PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets
TOKYO, Japan, 14 April 2025 -- PRISM BioLab, Co. Ltd., a leading discovery and development biotechnology...
Read More
Announcement: Guest Appearance on Radio NIKKEI 1’s The Money – Thursday, Hideaki Sakurai’s Kabutetsu
Our CEO, Takehara, recently appeared on Radio NIKKEI 1’s The Money – Thursday, Hideaki Sakurai’s Kabutetsu....
Read More
Announcement: Participation in LINK-J’s Miyaman’s Venture Talk vol.12
We are pleased to announce that our CEO, Takehara, will be speaking at Miyaman's Venture Talk...
Read More
December 26, 2024
Announcement of Appointment and Resignation of Directors
We are pleased to announce that at our Ordinary General Meeting of Shareholders held on December...
Read More
December 16, 2024
Our CEO Takahara Featured on “IRTV” Video Media
Our CEO, Takahara, recently appeared on IRTV, a video platform connecting investors and companies. YouTube: IRTV...
Read More
December 16, 2024
Event Report: CTO Toma Speaks at LINK-J and Merck Co-hosted Symposium
On Wednesday, November 13, 2024, our CTO, Toma, delivered a presentation at the symposium titled "Chemistry...
Read More
October 23, 2024
CEO Featured on Radio NIKKEI
We’re excited to share that our CEO, Takehara, was featured on Radio NIKKEI’s program, Leaders in...
Read More
October 7, 2024
Selected as a Finalist for the CITELINE Japan Award 2024 Biotech Company of the Year
We are honored to announce that we’ve been chosen as a finalist for the prestigious Biotech...
Read More
September 30, 2024
Notice of Article Published in the Nikkei
Prism BioLab in the Spotlight for Drug Discovery, Recognized by Major Pharma www.nikkei.com/article/DGXZQOUC06CAK0W4A900C2000000/
Read More